Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Cervical Cancer | Research

Predictors of cervical tumour size for outpatients with cervical cancer at the University of Gondar referral hospital: a retrospective study design

Authors: Chalachew Gashu, Aragaw Eshetie Aguade

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

Cervical cancer is one of the most serious threats to women's lives. Modelling the change in tumour size over time for outpatients with cervical cancer was the study's main goal.

Methods

A hospital conducted a retrospective cohort study with outpatients who had cervical cancer. The information about the tumour size was taken from the patient's chart and all patient data records between May 20, 2017, and May 20, 2021. The data cover 322 cervical cancer outpatients' basic demographic and medical information. When analysing longitudinal data, the linear mixed effect model and the connection between tumour sizes in outpatients were taken into consideration. A linear mixed model, a random intercept model, and a slope model were used to fit the data.

Result

A sample of 322 cervical cancer outpatients was examined, and 148 (or 46% of the outpatients) tested positive for HIV. The linear mixed model with a first-order autoregressive covariance structure revealed that a change in time of one month led to a 0.009 cm2 reduction in tumour size. For every kilogramme more in weight, the tumour size change in cervical cancer patients decreased considerably by 0.0098 cm2. The tumour size change in the cervical cancer patient who was HIV-positive was 0.4360 cm squared greater than that in the HIV-negative outpatients.

Conclusion

As a consequence, there was a significant association between the longitudinal change in tumour size and the predictor variables visit time, therapy, patient weight, cancer stage, HIV, oral contraceptive use, history of abortion, and smoking status.
Literature
2.
go back to reference Boutayeb A. The double burden of communicable and non-communicable diseases in developing countries. Trans R Soc Trop Med Hyg. 2006;100(3):191–9.CrossRefPubMed Boutayeb A. The double burden of communicable and non-communicable diseases in developing countries. Trans R Soc Trop Med Hyg. 2006;100(3):191–9.CrossRefPubMed
3.
go back to reference Finocchario-Kessler S, Wexler C, Maloba M, Mabachi N, Ndikum-Moffor F, Bukusi E. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Womens Health. 2016;16:1–25.CrossRef Finocchario-Kessler S, Wexler C, Maloba M, Mabachi N, Ndikum-Moffor F, Bukusi E. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Womens Health. 2016;16:1–25.CrossRef
4.
go back to reference Louie KS, De Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Heal. 2009;14(10):1287–302.CrossRef Louie KS, De Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Heal. 2009;14(10):1287–302.CrossRef
5.
go back to reference Gashu C, Tasfa B, Alemu C, Kassa Y. Assessing survival time of outpatients with cervical cancer: at the university of Gondar referral hospital using the Bayesian approach. BMC Womens Health. 2023;23(1):1–14.CrossRef Gashu C, Tasfa B, Alemu C, Kassa Y. Assessing survival time of outpatients with cervical cancer: at the university of Gondar referral hospital using the Bayesian approach. BMC Womens Health. 2023;23(1):1–14.CrossRef
6.
go back to reference Lim JNW, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care. 2017;26(1): e12444.CrossRef Lim JNW, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care. 2017;26(1): e12444.CrossRef
7.
8.
go back to reference Mekuria M, Edosa K, Endashaw M, Bala ET, Chaka EE, Deriba BS, et al. Prevalence of cervical cancer and associated factors among women attended cervical cancer screening center at gahandi memorial hospital Ethiopia. Cancer Inform. 2021;20: 11769351211068431.CrossRefPubMedPubMedCentral Mekuria M, Edosa K, Endashaw M, Bala ET, Chaka EE, Deriba BS, et al. Prevalence of cervical cancer and associated factors among women attended cervical cancer screening center at gahandi memorial hospital Ethiopia. Cancer Inform. 2021;20: 11769351211068431.CrossRefPubMedPubMedCentral
9.
go back to reference Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, et al. Cervix cancer in Sub-Saharan Africa: an assessment of cervical cancer management. JCO Glob Oncol. 2021;7:173–82.CrossRefPubMed Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, et al. Cervix cancer in Sub-Saharan Africa: an assessment of cervical cancer management. JCO Glob Oncol. 2021;7:173–82.CrossRefPubMed
10.
go back to reference FMoH E. Health sector transformation plan. Addis Ababa, Ethiopia; 2015. FMoH E. Health sector transformation plan. Addis Ababa, Ethiopia; 2015.
11.
go back to reference Aguade AE, Gashu C, Jegnaw T. The trend of change in cervical tumor size and time to death of hospitalized patients in northwestern Ethiopia during 2018–2022: Retrospective study design. Heal Sci Reports. 2023;6(2): e1121.CrossRef Aguade AE, Gashu C, Jegnaw T. The trend of change in cervical tumor size and time to death of hospitalized patients in northwestern Ethiopia during 2018–2022: Retrospective study design. Heal Sci Reports. 2023;6(2): e1121.CrossRef
12.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed
13.
go back to reference Assoumou SZ, Mabika BM, Mbiguino AN, Mouallif M, Khattabi A, Ennaji MM. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women. BMC Womens Health. 2015;15(1):1–7.CrossRef Assoumou SZ, Mabika BM, Mbiguino AN, Mouallif M, Khattabi A, Ennaji MM. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women. BMC Womens Health. 2015;15(1):1–7.CrossRef
14.
go back to reference Idowu A, Olowookere SA, Fagbemi AT, Ogunlaja OA. Determinants of Cervical Cancer Screening Uptake among Women in Ilorin, North Central Nigeria: A Community-Based Study. J Cancer Epidemiol. 2016;2016(Vili). Idowu A, Olowookere SA, Fagbemi AT, Ogunlaja OA. Determinants of Cervical Cancer Screening Uptake among Women in Ilorin, North Central Nigeria: A Community-Based Study. J Cancer Epidemiol. 2016;2016(Vili).
15.
go back to reference Belayneh T, Adefris M, Andargie G. Previous early antenatal service utilization improves timely booking: Cross-sectional study at university of Gondar Hospital, northwest Ethiopia. J Pregnancy. 2014; 2014. Belayneh T, Adefris M, Andargie G. Previous early antenatal service utilization improves timely booking: Cross-sectional study at university of Gondar Hospital, northwest Ethiopia. J Pregnancy. 2014; 2014.
16.
go back to reference Carey VJ, Wang Y. Working covariance model selection for generalized estimating equations. Stat Med. 2011;30(26):3117–24.CrossRefPubMed Carey VJ, Wang Y. Working covariance model selection for generalized estimating equations. Stat Med. 2011;30(26):3117–24.CrossRefPubMed
17.
go back to reference Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;963–74. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;963–74.
18.
go back to reference Diggle P, Diggle PJ, Heagerty P, Liang K-Y, Zeger S. Analysis of longitudinal data. Oxford: Oxford University Press; 2002.CrossRef Diggle P, Diggle PJ, Heagerty P, Liang K-Y, Zeger S. Analysis of longitudinal data. Oxford: Oxford University Press; 2002.CrossRef
19.
go back to reference Verbeke G. Linear mixed models for longitudinal data. In: Linear mixed models in practice. Springer; 1997. p. 63–153. Verbeke G. Linear mixed models for longitudinal data. In: Linear mixed models in practice. Springer; 1997. p. 63–153.
20.
go back to reference Littell RC, Pendergast J, Natarajan R. Modelling covariance structure in the analysis of repeated measures data. Stat Med. 2000;19(13):1793–819.CrossRefPubMed Littell RC, Pendergast J, Natarajan R. Modelling covariance structure in the analysis of repeated measures data. Stat Med. 2000;19(13):1793–819.CrossRefPubMed
21.
go back to reference Buta GB, Goshu AT, Worku HM. Bayesian joint modelling of disease progression marker and time to death event of HIV/AIDS patients under ART follow-up. Br J Med Med Res. 2015;5(8):1034.CrossRef Buta GB, Goshu AT, Worku HM. Bayesian joint modelling of disease progression marker and time to death event of HIV/AIDS patients under ART follow-up. Br J Med Med Res. 2015;5(8):1034.CrossRef
22.
go back to reference Lange N, Ryan L. Assessing normality in random effects models. Ann Stat. 1989;624–42. Lange N, Ryan L. Assessing normality in random effects models. Ann Stat. 1989;624–42.
23.
go back to reference Singer JD, Willett JB, Willett JB. Applied longitudinal data analysis: Modeling change and event occurrence. Oxford: Oxford University Press; 2003.CrossRef Singer JD, Willett JB, Willett JB. Applied longitudinal data analysis: Modeling change and event occurrence. Oxford: Oxford University Press; 2003.CrossRef
24.
go back to reference Smith JS, Green J, Berrington de Gonzalez A, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003;361(9364):1159–67.CrossRefPubMed Smith JS, Green J, Berrington de Gonzalez A, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003;361(9364):1159–67.CrossRefPubMed
25.
go back to reference Wassie M, Fentie B, Asefa T. Determinants of Mortality among Cervical Cancer Patients Attending in Tikur Anbessa Specialized Hospital, Ethiopia : Institutional-Based Retrospective Study. 2021;2021. Wassie M, Fentie B, Asefa T. Determinants of Mortality among Cervical Cancer Patients Attending in Tikur Anbessa Specialized Hospital, Ethiopia : Institutional-Based Retrospective Study. 2021;2021.
Metadata
Title
Predictors of cervical tumour size for outpatients with cervical cancer at the University of Gondar referral hospital: a retrospective study design
Authors
Chalachew Gashu
Aragaw Eshetie Aguade
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01296-z

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue